Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    9272483 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)
Condition: Parkinson's Disease
Interventions: Drug: carbidopa/l-dopa;   Drug: carbidopa/l-dopa/entacapone;   Drug: Stalevo;   Procedure: [123I]-IBZM imaging

Study has passed its completion date and status has not been verified in more than two years.